Infections can be a major complication after cardiothoracic surgery and can greatly impact on the recovery, morbidity and mortality of patients. However, accurately diagnosing infection in this setting is challenging because damaged tissue due to the surgical intervention often leads to the production of pro-inflammatory cytokines and induces a nonspecific systemic inflammatory response syndrome 1 . In addition, the normal healing process, haematoma in the surgical site, transfusion of blood or blood products, deep venous thrombosis and adverse drug reactions may also provoke fever and a systemic inflammatory response syndrome in the postoperative course. This diagnostic uncertainty ultimately leads to antibiotic overconsumption and emergence of multi-resistance bacteria. Thus a reliable diagnostic marker would be of great benefit in this setting.
Enormous attempts have been undertaken to correlate levels of different mediators, particularly C-reactive protein (CRP) and procalcitonin (PCT), with the presence of bacterial infections and sepsis 2, 3 . PCT has been demonstrated to be clinically useful in the diagnosis of bacterial infections, particularly in respiratory tract infections and in sepsis 4 . Antibiotic stewardship based on PCT cut-off ranges has shown effectiveness in patients with suspected respiratory tract infection [5] [6] [7] [8] [9] and in septic patients from the intensive care unit (ICU) 10, 11 . The diagnostic value of PCT to diagnose infections for specific surgical settings (such as in cardiac surgery after cardiopulmonary bypass, lung decortications, major neurosurgery, orthopaedic surgery and abdominal surgery) has been assessed [12] [13] [14] [15] [16] [17] [18] [19] . In addition, a recent trial has advanced the field by demonstrating that PCT guidance for antibiotic utilisation reduces unnecessary antibiotic consumption without increasing the risk of untreated infection in postoperative patients
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SUMMARy
Procalcitonin is a marker of significant bacterial infection. With Food and Drug Administration approval of a new high-sensitive procalcitonin assay in the United States, we felt it would be important to assess its normal elevation and time characteristics, as compared to other inflammatory markers in patients undergoing routine cardiac surgery. This is a prospective observational study including consecutive patients after routine cardiac surgery. Blood was sampled preoperatively, immediately postoperatively and daily until discharge or to postoperative day five for measurement of blood markers of infection. Patients were classified into different groups based on the type of surgery (on-pump and off-pump) and progression of recovery (complicated and uncomplicated). Patients after coronary artery bypass grafting off-pump (n=61) had significantly lower mean (0.90 vs 1.13 µg/l, P=0.006) and peak (2.09 vs 2.35 µg/l, P=0.002) procalcitonin levels in the postoperative course compared to patients with either on-pump valve surgery alone, on-pump coronary artery bypass grafting alone (n=28) or valve surgery with coronary artery bypass grafting (n=16). In addition, mean and peak procalcitonin levels were significantly higher (P=0.004 and P=0.002 respectively) in the 60 patients with a complicated course. This study provides insights into 'normal' kinetics of a new high-sensitive procalcitonin assay after different types of cardiac surgery, and in patients with and without a complicated postoperative course. Our results suggest that using a single procalcitonin level to guide antibiotic therapy decisions during the early period after major cardiac surgery may not be useful and that monitoring its kinetic may be the preferred strategy.
Serum procalcitonin after cardiopulmonary Surgery
Anaesthesia and Intensive Care, Vol. 40, No. 5, September 2012 in a surgical ICU 20 . In this randomised controlled trial, physicians were advised to stop antibiotic treatment when PCT showed a 'normal' decrease in the postoperative course below the cut-off level of 1.0 ng/ml. Thus in-depth knowledge of normal postoperative kinetics of PCT is of great importance.
Furthermore, with Food and Drug Administration approval of a new high sensitivity assay for PCT in the United States, we felt it would be important to assess the normal elevation and time characteristics of PCT as compared to other inflammatory markers in patients undergoing different types of cardiac surgery.
METHODS

Study design and patient sample
This study was conducted in the cardiac surgical ICU of the Morton Plant Hospital in Clearwater, Florida, a 687-bed community referral centre. Between 1 May and 13 September 2009, a total of 105 consecutive patients with elective cardiothoracic surgery were prospectively enrolled prior to surgery and followed until hospital discharge. We included adult patients (>18 years of age) with elective stable coronary artery bypass graft surgery with or without aortic valve repair/replacement or mitral valve annuloplasy/ replacement. Exclusion criteria included a recent infection and/or antibiotic treatment within one week preoperatively, a fever of >37.5°C, patients on oral or intravenous corticosteroids and patients with known immune dysfunction, active congestive heart failure and/or recovering from cardiogenic shock. For all patients we obtained demographic, clinical, microbiological, radiographic and laboratory data prior to surgery and during follow-up until hospital discharge, as well as data from the Society of Thoracic Surgeons database for this cohort of patients. All patients undergoing coronary artery bypass surgery had antibiotic prophylaxis with Ancef ® (SmithKline Beecham, PA, USA) or clindamycin for penicillin allergy. Patients undergoing valve surgery were given Ancef and Gentamicin in the hour prior to incision, according to Centers for Medicare and Medicaid Services guidelines. The local Institutional Review Board (IRB 2008.024) has approved this study and written informed consent was obtained from all study participants.
Blood collection and measurement of inflammatory markers
In all patients, blood was collected preoperatively, immediately upon arrival to the cardiac surgical ICU and then daily in the mornings for five consecutive days or until day of discharge. PCT was measured with a high sensitivity VIDAS ® B.R.A.H.M.S PCT assay (bioMérieux, Marcy L'Etoile, France); an automated heterogeneous sandwich immunoassay with fluorescence detection. This assay method is based on antibodies against the calcitonin and katacalcin domains of the prohormone. Total assay time of the VIDAS method is 20 minutes with a measuring range of 0.05-200 µg/l and a functional sensitivity of 0.09 µg/l. CRP concentrations were determined by an enzyme immunoassay having a detection limit of <5 mg/dl (EMIT, Merck Diagnostica).
Definitions
A patient was identified as having a complicated course subsequent to surgery based on the presence of at least one of the following conditions as listed on the Society of Thoracic Surgeons guidelines: renal failure, neurological event, stroke, perioperative myocardial infarction, other non-cardiac such as suspicion of infection, other cardiac, bleed/tamponade, postoperative creatinine >1.8mg/dl (158 µmol/l) (or increase of more than 0.3 mg/dl [26.4 µmol/l]) from preoperative level, atrial fibrillation, postoperative length-of-stay >7 days, initial ventilator hours >6 hours. Infection was assumed if the treating physicians decided to prescribe antibiotics in the patients due to their clinical presentation (i.e. development of fever, local signs of surgical site infection).
Statistical analyses
First, we used descriptive statistics, including median and interquartile range and frequencies to describe the populations, as appropriate. For each blood marker, the mean value and the maximum value over the postoperative course (immediately after surgery and on days one, two, three, four and five after surgery) for each patient were used for each patient in the comparisons between complicated and uncomplicated course groups and on-pump and off-pump surgery groups. Comparisons of medians between the groups were performed using the Wilcoxon two-sample test. All reported confidence intervals are two-sided 95% intervals, and tests were performed at the two-sided 5% significance level. All analyses were performed with SAS 9.2. (SAS Institute Inc., Cary, NC, USA).
RESULTS
Study population
A total of 105 patients (76% male) with a median age of 68 were included in this study. Most surgical procedures were elective (83%) and the majority of patients underwent coronary artery bypass surgery (61%) followed by heart valve replacement (21%) and coronary artery bypass plus heart valve replacement (15%). A cardiopulmonary bypass pump was used in 42% of cases. The median duration of ventilation during surgery was 153 minutes (interquartile range 118-215 minutes), and the median duration of surgery was 185 minutes (interquartile range 149-228 minutes). Additional baseline characteristics and follow-up data are presented in Table 1 .
Serious complications were uncommon but one patient (0.95%) died on postoperative day ten; Table 2 lists all complications. A total of three patients (3%) had a neurological event and three patients (3%) developed an infection in the postoperative course (pseudomonas pneumonia [n=1], peritonitis after colonic perforation [n=1], urinary tract infection [n=1]). These were the only patients who had received antibiotics in the postoperative course. Increase of cardiac enzymes as evidence for a perioperative myocardial infarction occurred in 25% of patients, and 20% of the study patients had postoperative atrial fibrillation. Other common complications included postoperative renal failure (10%), postoperative length-of-stay >7 days (14%) and initial ventilation >6 hours (10%). Collectively, a total of 60 patients (57%) had at least one of the complications described here during the postoperative period. Of note, some patients had more than one complication and the numbers therefore add up to more than 100%.
Course of PCT, white blood cells and CRP after cardiac surgery
Blood markers of PCT, white blood cells (WBC) and CRP were assessed before surgery, immediately after surgery and on postoperative days one, two, three, four and five. PCT showed an increase after one to two days to mean peak levels of 1.61 on day two or three and a sharp decline after day three. WBC and CRP showed a slower increase and also a slower decrease after surgery.
Complicated and uncomplicated postoperative course
When comparing patients with a complicated operative and/or postoperative course to patients 
Complications,
All patients, with an uncomplicated course, we found significantly higher PCT levels (P=0.004) and significantly higher peak PCT values (P=0.002) in complicated courses (Table 3) . Similarly, average CRP levels and CRP peak levels were significantly higher in complicated cases compared to uncomplicated cases, while average and peak WBC values were similar in both groups. Figure 1A illustrates the course of PCT, CRP and WBC values in complicated and uncomplicated cases.
Excluding data of the three patients with infection did not significantly alter the profiles of CRP and PCT; patients with complications other than infection still had significantly raised CRP and PCT levels.
On-pump and off-pump surgery Finally, we compared patients undergoing on-pump surgery to patients undergoing off-pump surgery. Average and peak PCT values were significantly increased in on-pump patients ( Table 3 ) and these patients tended to have an earlier PCT peak compared to off-pump patients ( Figure 1B) . No difference was found for CRP and WBC values.
DISCUSSION
Within this prospective cohort study of patients undergoing major cardiac surgery, we investigated time profiles of PCT, WBC and CRP in postoperative course. We found significant increases of PCT within the first three days, particularly in patients with complicated postoperative courses and in patients with on-pump surgery, and a sharp decline thereafter. Similarly, CRP increased postoperatively within the first three days with a less pronounced decrease, and WBC was increased during the whole five-day surveillance period. Because knowledge about the kinetics of blood markers of infection and inflammation is a prerequisite for their sound interpretation in clinical practice, this study provides helpful information.
A recent study investigated time kinetics of PCT and CRP after open heart surgery in a paediatric patient population and found that patients with a systemic inflammatory response syndrome and organ failure had increased peak PCT levels, and that PCT elevation had a high predictive value for mortality and organ failure development, whereas C-reactive protein levels did not 21 . Similar results were also reported in a cohort of paediatric patients undergoing cardiac surgery with cardiopulmonary bypass 22 . PCT levels on day one correlated with cardiopulmonary bypass duration, cross-clamping time and use of aprotinin and while PCT levels peaked on day one, CRP levels remained elevated during the first two postoperative days. Similarly, Madershahian and colleagues investigated PCT levels in patients undergoing heart transplantation and found consistently lower PCT levels in patients with an uneventful course, but found that PCT levels more frequently increased in patients with postoperative complications and were even associated with an increased mortality when early postoperative values exceeded 80 µg/l. Based on this analysis, the author recommended that PCT levels in the first few days following cardiac transplantation might help to identify patients at risk when concentrations exceed the 'normal' posttransplantation range 23 PCT in postoperative patients after cardiac surgery 17 . They concluded that dynamics of PCT levels, rather than absolute values, are important in identifying patients with complications of infection after cardiac surgery. These studies show the need for carefully conducted observational studies to characterise the normal PCT kinetics after surgery. In this regard, our study significantly contributes to the current literature, showing a PCT increase within the first two to three days postoperatively and a short decline thereafter using the new high sensitivity Food and Drug Administration approved assay. It is important to note that a PCT assay was not commercially available in the United States until 2008.
Our study was a single-centre study and not powered to investigate the association of blood markers with postoperative infections or mortality; we found evidence for infection in only three patients and only one patient died in the postoperative course. However, other studies found higher PCT values in the postoperative course of patients after cardiac surgery with infection, compared to patients without infection 24 . Also, we focused on only PCT as a marker of bacterial infection and future studies should also compare this marker with other sepsis markers, such as interleukin-6 or endotoxin.
Another major limitation of our study is the observational design and the lack of a control group; thus, from our data it remains unclear whether using PCT in the postoperative course truly improves patient management. However, there are a number of randomised, controlled studies where clinical algorithms were used based on PCT values for antibiotic stewardship 25 . Unlike CRP and WBC, different studies have shown that PCT can be used for antibiotic stewardship and safely reduce antibiotic exposure [5] [6] [7] 10, 26, 27 . Importantly, in these studies, high sensitivity PCT assays and cut off ranges of 0.1-0.25 ng/ml were used to maximise sensitivity and, thus, the safety of patients. This concept was proven successful because PCT remained low in patients without infections. In contrast, the present cohort of patients has moderately elevated PCT levels, which limits the diagnostic potential of PCT, especially for diagnosing 'low grade' infection as often suspected in patients after surgery; knowledge of the normal PCT kinetics is mandatory for safe use of this marker in clinical practice. Importantly, a German study has recently assessed the effect of PCT guidance in 110 surgical ICU patients with suspected bacterial infections 20 . According to the study protocol, antibiotic therapy in the PCT-guided group was discontinued if clinical signs and symptoms of infection improved and PCT decreased to less than 1 µg/l, or if the PCT value was more than 1 µg/l but had dropped to 25-35% of the initial value over three days. Within this study, PCT guidance resulted in a reduction of antibiotic therapy from 7.9-5.9 days and similar medical outcomes. In addition, the length of intensive care treatment in the PCT-guided group was significantly shorter than that in the control group (15.5 vs 17.7 days). If these results are confirmed in future studies, including postoperative patients, PCT may become a promising marker for reducing antibiotic exposure in postoperative patients and for early identification of postoperative complications.
CONCLUSION
In conclusion, within this study we describe PCT kinetics in postoperative patients undergoing routine off-pump and on-pump cardiac surgery, as well as the observation of the complicated and uncomplicated perioperative period and thereby provide clinicians evidence of what might be considered 'normal' in the postoperative course. Our results suggest that using a single absolute PCT level to guide antibiotic therapy decisions early after cardiac surgery may not be useful, but that monitoring the course of PCT may be the preferred strategy. Further prospective studies investigating the cost-effectiveness and safety of using PCT-based protocols are needed to guide antibiotic therapy after major cardiac surgery.
